PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Local Administration of Interleukin-1 Receptor Antagonist Improves Diabetic Wound Healing.

Mouse / Wound

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29553981 ↗2018Reported benefit

Local Administration of Interleukin-1 Receptor Antagonist Improves Diabetic Wound Healing.

MouseWounddb/db (BKS.Cg-m +/+) diabetic miceMalen = 7 animals, 14 wounds (7 treated and 7 vehicle)Local subcutaneous injection circumferentially into the wound margins70 microlitres containing 5 microlitres anakinra (0.75 mg i…One hour after wounding

Model: Splinted full-thickness excisional wound model with two 6 mm punch biopsy wounds per animal stented with 7 mm silicone splints

Treated wounds were significantly smaller than vehicle-treated wounds at day 7 (p less than 0.02) and day 14 (p less than 0.03), with the day 21 difference not significant, and showed significantly less neutrophil and macrophage infiltration.

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.